181 related articles for article (PubMed ID: 31243048)
1. Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis.
Selyunin AS; Hutchens S; McHardy SF; Mukhopadhyay S
Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31243048
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen Derivatives Alter Retromer-Dependent Endosomal Tubulation and Sorting to Block Retrograde Trafficking of Shiga Toxins.
Selyunin AS; Nieves-Merced K; Li D; McHardy SF; Mukhopadhyay S
Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34203879
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking.
Selyunin AS; Iles LR; Bartholomeusz G; Mukhopadhyay S
J Cell Biol; 2017 Oct; 216(10):3249-3262. PubMed ID: 28883040
[TBL] [Abstract][Full Text] [Related]
4. A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
Selyunin AS; Mukhopadhyay S
Traffic; 2015 Dec; 16(12):1270-87. PubMed ID: 26420131
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Early Endosome-to-Golgi Transport of Shiga Toxins as a Therapeutic Strategy.
Li D; Selyunin A; Mukhopadhyay S
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456007
[TBL] [Abstract][Full Text] [Related]
6. Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis.
Mukhopadhyay S; Linstedt AD
Science; 2012 Jan; 335(6066):332-5. PubMed ID: 22267811
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin-binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms.
Mukhopadhyay S; Redler B; Linstedt AD
Mol Biol Cell; 2013 Aug; 24(15):2311-8. PubMed ID: 23761068
[TBL] [Abstract][Full Text] [Related]
8. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.
Flagler MJ; Strasser JE; Chalk CL; Weiss AA
Infect Immun; 2007 Feb; 75(2):760-5. PubMed ID: 17101648
[TBL] [Abstract][Full Text] [Related]
10. Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.
Tarragó-Trani MT; Storrie B
Adv Drug Deliv Rev; 2007 Aug; 59(8):782-97. PubMed ID: 17669543
[TBL] [Abstract][Full Text] [Related]
11. Production of shiga toxin by Escherichia coli measured with reference to the membrane vesicle-associated toxins.
Yokoyama K; Horii T; Yamashino T; Hashikawa S; Barua S; Hasegawa T; Watanabe H; Ohta M
FEMS Microbiol Lett; 2000 Nov; 192(1):139-44. PubMed ID: 11040442
[TBL] [Abstract][Full Text] [Related]
12. Exosome-associated Shiga toxin 2 is released from cells and causes severe toxicity in mice.
Watanabe-Takahashi M; Yamasaki S; Murata M; Kano F; Motoyama J; Yamate J; Omi J; Sato W; Ukai H; Shimasaki K; Ikegawa M; Tamura-Nakano M; Yanoshita R; Nishino Y; Miyazawa A; Natori Y; Toyama-Sorimachi N; Nishikawa K
Sci Rep; 2018 Jul; 8(1):10776. PubMed ID: 30018364
[TBL] [Abstract][Full Text] [Related]
13. Different roles of the C-terminal end of Stx1A and Stx2A for AB5 complex integrity and retrograde transport of Stx in HeLa cells.
Kymre L; Simm R; Skotland T; Sandvig K
Pathog Dis; 2015 Dec; 73(9):ftv083. PubMed ID: 26443836
[TBL] [Abstract][Full Text] [Related]
14. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
[TBL] [Abstract][Full Text] [Related]
15. Differences in Ribosome Binding and Sarcin/Ricin Loop Depurination by Shiga and Ricin Holotoxins.
Li XP; Tumer NE
Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28398250
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
[TBL] [Abstract][Full Text] [Related]
17. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
Li B; Liu H; Wang W
BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
[TBL] [Abstract][Full Text] [Related]
18. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
Wen SX; Teel LD; Judge NA; O'Brien AD
Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
[TBL] [Abstract][Full Text] [Related]
19. Shiga-like toxin binds with high avidity to multivalent O-linked blood group P1 determinants on mucin-type fusion proteins.
Maria Cherian R; Gaunitz S; Nilsson A; Liu J; Karlsson NG; Holgersson J
Glycobiology; 2014 Jan; 24(1):26-38. PubMed ID: 24082034
[TBL] [Abstract][Full Text] [Related]
20. Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin.
Lauvrak SU; Torgersen ML; Sandvig K
J Cell Sci; 2004 May; 117(Pt 11):2321-31. PubMed ID: 15126632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
